Suppression chromogranin-A release neuroendocrine sources man pharmacological studies Chromogranin-A CgA acidic soluble protein ubiquitous occurrence normal human neuroendocrine tissues many potential tissue sources CgA immunoreactivity unstimulated CgA question effects selective nonselective suppression secretion several sites neuroendocrine system Selective disruption sympathetic outflow trimethaphan basal CgA sympathetic neurons CgA Plasma CgA patients unilateral bilateral adrenalectomy range normal subjects adrenal medulla major source basal CgA Selective suppression variety anterior posterior pituitary cell types plasma levels usual resident peptide hormones plasma CgA unperturbed propranolol treatment plasma CgA unaltered Secretin plasma PTH calcitonin plasma CgA levels hand widespread nonselective suppression variety neuroendocrine secretory cells somatostatin plasma CgA Plasma catecholamines somatostatin infusion somatostatin CgA release nonsympathoadrenal sources infusion somatostatin plasma epinephrine increment response insulin-induced hypoglycemia plasma CgA somatostatin cessation findings somatostatin transport stimulation-released CgA adrenal medulla circulation conclusion adrenal medulla major tissue source CgA immunoreactivity man neuroendocrine sites sympathetic axons multiple endocrine glands basal concentration CgA 